XRCC3 and prostate cancer: The presence of the GG genotype in both polymorphic sites of RAD51 and XRCC3 increases the risk of prostate cancer (OR = 2.782, p = 0.038 for rs5030789; OR = 1.986, p = 0.041 for rs1799796).